Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro
Author:
Funder
Czech Science Foundation
Charles University
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference39 articles.
1. Targeting CDK4/6 in patients with cancer;Hamilton;Cancer Treat. Rev.,2016
2. FDA approval: palbociclib for the treatment of postmenopausal patients with estrogen receptor-positive, HER2-negative metastatic breast cancer;Beaver;Clin. Cancer Res.,2015
3. Ribociclib: first global approval;Syed;Drugs,2017
4. Spectrum and degree of CDK drug interactions predicts clinical performance;Chen;Mol. Cancer Ther.,2016
5. Chemoproteomics reveals novel protein and lipid kinase targets of clinical CDK4/6 inhibitors in lung cancer;Sumi;ACS Chem. Biol.,2015
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs;Frontiers in Pharmacology;2024-07-24
2. A telomere-related gene risk model for predicting prognosis and treatment response in acute myeloid leukemia;Heliyon;2024-06
3. Predicting drug–drug interactions in breast cancer patients treated with CDK4/6 inhibitors and forward planning;Expert Opinion on Drug Metabolism & Toxicology;2024-04-02
4. Differential effects of dietary polyphenols on oral pharmacokinetics of cyclin-dependent kinase inhibitors in rats: a mechanistic framework for in vitro–in vivo extrapolation;Journal of Pharmacy and Pharmacology;2023-12-12
5. Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature;Brain, Behavior, & Immunity - Health;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3